π
|
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection.
34 auth.
M. Yuen,
S. Lim,
R. PleΕniak,
K. Tsuji,
H. Janssen,
C. Pojoga,
A. Gadano,
C. Popescu,
T. Stepanova,
T. Asselah,
Gheorghe Diaconescu,
H. Yim,
J. Heo,
E. Janczewska,
Alexander Wong,
...
N. Idriz,
M. Imamura,
G. Rizzardini,
K. Takaguchi,
P. Andreone,
M. Arbune,
J. Hou,
Sung-Jae Park,
A. VΓ’ΘΔ,
J. Cremer,
R. Elston,
Tamara LukiΔ,
Geoff Quinn,
L. Maynard,
Stuart Kendrick,
H. Plein,
F. Campbell,
M. Paff,
D. Theodore
|
6 |
2022 |
6 π
|
π¬
|
Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled field trial
K. Mari,
L. Maynard,
H. Eun,
B. Lebreux
|
6 |
2003 |
6 π¬
|
π¬
|
Therapeutic effects of recombinant feline interferon-omega on feline leukemia virus (FeLV)-infected and FeLV/feline immunodeficiency virus (FIV)-coinfected symptomatic cats.
K. de Mari,
L. Maynard,
A. Sanquer,
B. Lebreux,
H. Eun
|
6 |
2004 |
6 π¬
|
π¬
|
Therapeutic Effects of Recombinant Feline Interferon-co on Feline Leukemia Virus (FeLV)-Infected and FeLV/Feline Immunodeficiency Virus (FIV)-Coinfected Symptomatic Cats
K. Mari,
L. Maynard,
A. Sanquer,
B. Lebreux,
H. Eun
|
6 |
2004 |
6 π¬
|
π¬
|
Comparative study on the short term efficacy and adverse effects of miltefosine and meglumine antimoniate in dogs with natural leishmaniosis
M. Mateo,
L. Maynard,
C. Vischer,
P. Bianciardi,
G. MirΓ³
|
5 |
2009 |
5 π¬
|
π¬
|
Clinical efficacy and tolerance of miltefosine in the treatment of canine leishmaniosis
V. Woerly,
L. Maynard,
A. Sanquer,
H. Eun
|
5 |
2009 |
5 π¬
|
π¦
|
Comparison of two shampoos for the treatment of canine Malassezia dermatitis: a randomised controlled trial.
L. Maynard,
C. Rème,
S. Viaud
|
5 |
2011 |
5 π¦
|
π¬
|
Therapeutic efficacy of topical hydrocortisone aceponate in experimental flea-allergy dermatitis in dogs.
S. Bonneau,
V. Skowronski,
A. Sanquer,
L. Maynard,
H. Eun
|
4 |
2009 |
4 π¬
|